James G. Bender, VP Product Development & Mfg at ImmunoCellular Therapeutics, Ltd. (IMUC), sold 7,000 shares at $3.59 ($25K) on 2012-06-01, disclosed to the SEC on 2012-06-06.
Open-market sale of $25k IMUC by VP Product Development & Mfg. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.59 | 1,500 | $5K | 21.4% |
| 2 | $3.60 | 4,900 | $18K | 70.0% |
| 3 | $3.61 | 600 | $2K | 8.6% |
| Total | $3.60 avg | 7,000 | $25K | 100% |
| Filing → |